The Relationship between Gastroduodenal Pathologies and Helicobacter pylori cagL (Cytotoxin-Associated Gene L) Polymorphism.
Journal
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
ISSN: 2148-5607
Titre abrégé: Turk J Gastroenterol
Pays: Turkey
ID NLM: 9515841
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
medline:
25
4
2023
pubmed:
16
2
2023
entrez:
15
2
2023
Statut:
ppublish
Résumé
The polymorphisms in the region between 58 and 62 amino acids of the 194-amino acid CagL protein (CagL hypervariable motif) affect the binding affinity of CagL to integrin α5β1 (ITGA5B1) receptor in host epithelial cells and have an effect on the development of various gastrointestinal diseases. We aimed to evaluate the associations of gastroduodenal pathologies, with the polymorphisms of cagL gene of Helicobacter pylori (H. pylori) and also associations between vacA genotypes and cagL polymorphisms. A total of 19 gastric cancer, 16 duodenal ulcer, and 26 non-ulcer dyspepsia patients were included in this case-control study. All cases had H. pylori. A fragment of 651 bp from gene cagL (hp0539) and cagA, vacA genes was amplified by polymerase chain reaction. Purified polymerase chain reaction products were sequenced by Sanger sequencing, and nucleotide sequences were translated into amino acid sequences. All of the H. pylori strains had cagL and cagA genes. In the 16 (84%) gastric cancer cases, the D58 amino acid polymorphism was significant than the 4 (15.4%) duodenal ulcer cases (P = .029), and the D58/K59 amino acid polymorphism was significant in 12 (63.1%) of the gastric cancer cases than 1 (3.85%) duodenal ulcer case (P = .008). D58/K59 and DKIGQ (n = 10; 52.63%) were the most common polymorphisms in the gastric cancer and were associated with the vacA genotype s1/m2, respectively (P = .022 and P = .008). The D58/K59 amino acid polymorphism was found to have a significant Odds Ratio (OR) value of 8.9 (P = .0017) in multivariate logistic regression analysis. The risk of gastric cancer development is 8.9 times higher with D58/K59 polymorphism.
Sections du résumé
BACKGROUND
The polymorphisms in the region between 58 and 62 amino acids of the 194-amino acid CagL protein (CagL hypervariable motif) affect the binding affinity of CagL to integrin α5β1 (ITGA5B1) receptor in host epithelial cells and have an effect on the development of various gastrointestinal diseases. We aimed to evaluate the associations of gastroduodenal pathologies, with the polymorphisms of cagL gene of Helicobacter pylori (H. pylori) and also associations between vacA genotypes and cagL polymorphisms.
METHODS
A total of 19 gastric cancer, 16 duodenal ulcer, and 26 non-ulcer dyspepsia patients were included in this case-control study. All cases had H. pylori. A fragment of 651 bp from gene cagL (hp0539) and cagA, vacA genes was amplified by polymerase chain reaction. Purified polymerase chain reaction products were sequenced by Sanger sequencing, and nucleotide sequences were translated into amino acid sequences.
RESULTS
All of the H. pylori strains had cagL and cagA genes. In the 16 (84%) gastric cancer cases, the D58 amino acid polymorphism was significant than the 4 (15.4%) duodenal ulcer cases (P = .029), and the D58/K59 amino acid polymorphism was significant in 12 (63.1%) of the gastric cancer cases than 1 (3.85%) duodenal ulcer case (P = .008). D58/K59 and DKIGQ (n = 10; 52.63%) were the most common polymorphisms in the gastric cancer and were associated with the vacA genotype s1/m2, respectively (P = .022 and P = .008). The D58/K59 amino acid polymorphism was found to have a significant Odds Ratio (OR) value of 8.9 (P = .0017) in multivariate logistic regression analysis.
CONCLUSIONS
The risk of gastric cancer development is 8.9 times higher with D58/K59 polymorphism.
Identifiants
pubmed: 36789984
doi: 10.5152/tjg.2023.22274
pmc: PMC10210604
doi:
Substances chimiques
Bacterial Proteins
0
Amino Acids
0
Antigens, Bacterial
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
346-355Références
Gastric Cancer. 2013 Jul;16(3):435-9
pubmed: 22941498
Int J Cancer. 2020 May 15;146(10):2773-2783
pubmed: 31376284
PLoS One. 2015 Jul 21;10(7):e0133531
pubmed: 26196862
Mol Biol Evol. 1987 Jul;4(4):406-25
pubmed: 3447015
Structure. 2013 Nov 5;21(11):1931-41
pubmed: 24076404
Toxins (Basel). 2019 Nov 19;11(11):
pubmed: 31752394
J Med Microbiol. 2015 Oct;64(10):1117-23
pubmed: 26198695
Microb Pathog. 2017 Jun;107:413-418
pubmed: 28433795
J Theor Biol. 1965 Mar;8(2):357-66
pubmed: 5876245
Cancer Med. 2019 Apr;8(4):1619-1632
pubmed: 30873747
PLoS One. 2014 Jun 03;9(6):e97782
pubmed: 24893039
Helicobacter. 2018 Sep;23 Suppl 1:e12516
pubmed: 30203582
J Infect Dis. 2016 Jun 15;213(12):1927-31
pubmed: 26908724
Turk J Gastroenterol. 2015 Jul;26(4):297-303
pubmed: 26039002
World J Gastroenterol. 2019 Sep 7;25(33):4870-4884
pubmed: 31543679
Lancet. 1984 Jun 16;1(8390):1311-5
pubmed: 6145023
Infect Immun. 2019 Mar 25;87(4):
pubmed: 30692181
PLoS One. 2013 Aug 29;8(8):e72735
pubmed: 24009701
Front Cell Infect Microbiol. 2012 May 23;2:70
pubmed: 22919661
Gut Pathog. 2017 Apr 21;9:21
pubmed: 28439300
Gut Liver. 2019 Nov 15;13(6):596-603
pubmed: 31394893
Gut Pathog. 2019 Feb 13;11:5
pubmed: 30805032
Acta Gastroenterol Belg. 2020 Jul-Sep;83(3):385-392
pubmed: 33094584
Helicobacter. 2019 Jun;24(3):e12583
pubmed: 30950121
Mol Biol Rep. 2019 Dec;46(6):5703-5712
pubmed: 31359381
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904